Sun Pharma Challenges US Antitrust Ruling
Indian Firm Seeks Leave To Appeal Antitrust Judgement
India’s Sun Pharma has sought leave to appeal a US court ruling rejecting the company’s bid for dismissal of a multidistrict antitrust lawsuit involving its troubled Ranbaxy subsidiary.
